Zonisamide for Heavy Drinkers With Bipolar Disorder.
Phase of Trial: Phase II
Latest Information Update: 18 Jan 2017
At a glance
- Drugs Zonisamide (Primary)
- Indications Alcoholism; Bipolar disorders
- Focus Biomarker; Therapeutic Use
- Acronyms ZNS-BP
- 13 Jul 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Sep 2015 to 1 Sep 2016.
- 13 Jul 2015 According to the ClinicalTrials.gov record, planned primary completion date changed to 1 Apr 2016.
- 19 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.